9:00am - 5:00pm

Office Hours Mon. - Fri.

800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Archive

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

Condition Malignant Mesothelioma Estimated Enrollment: 840 Age Group: 18 Years and older   (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Allocation: Randomized|Primary Purpose: Treatment Study ID Numbers: BTS-MRC-MS01|CDR0000347461|ISRCTN54469112|EU-20349 Study First Received: January 9, 2004 Last Updated: August 6, 2013 Estimated Primary Completion Date: null Primary Outcome Measures: Overall survival|Palliation of chest pain, breathlessness, malaise (e.g., feeling weak, tiredness, anorexia), and sweating attacks|Performance status as measured by WHO grade|Analgesic usage|Toxicity as measured by the NCIC CTC|Quality of life as assessed by the European Organization for Research and Treatment of Cancer|Tumor response as measured by the RECIST criteria|Progression-free survival as measured by CT scan Sponsors and Collaborators: Medical Research Council|National Cancer Institute (NCI) Result...

Continue reading

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Condition Malignant Mesothelioma Estimated Enrollment: 6 Age Group: 18 Years and older   (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment Study ID Numbers: CDR0000066157|P30CA006927|FCCC-96087|NCI-G98-1401 Study First Received: November 1, 1999 Last Updated: April 16, 2013 Estimated Primary Completion Date: December 1999 Primary Outcome Measures: Sponsors and Collaborators: Fox Chase Cancer Center|National Cancer Institute (NCI) Result Received: No Study Results Posted Website Link: https://ClinicalTrials.gov/show/NCT00003263...

Continue reading

SU5416 in Treating Patients With Malignant Mesothelioma

Condition Malignant Mesothelioma Estimated Enrollment: 45 Age Group: 18 Years and older   (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment Study ID Numbers: NCI-2012-02351|UCCRC-10409|UCCRC-NCI-44|NCI-44|CDR0000068023 Study First Received: July 5, 2000 Last Updated: May 31, 2013 Estimated Primary Completion Date: February 2007 Primary Outcome Measures: Sponsors and Collaborators: National Cancer Institute (NCI) Result Received: No Study Results Posted Website Link: https://ClinicalTrials.gov/show/NCT00006014...

Continue reading

Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

Condition Malignant Mesothelioma Estimated Enrollment: 60 Age Group: 18 Years and older   (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Allocation: Non-Randomized|Primary Purpose: Treatment Study ID Numbers: CDR0000564058|COL-ALIMESO|INCA-RECF0441|COL-2006-04 Study First Received: October 5, 2007 Last Updated: May 14, 2011 Estimated Primary Completion Date: May 2011 Primary Outcome Measures: Individual dosage-adapted protocol|Relationship between pharmacokinetic and pharmacodynamic parameters|Pharmacokinetics|Pharmacogenetic variations (MTHFR, TS, GSTpi, ERCC1, XPD) Sponsors and Collaborators: Centre Oscar Lambret|National Cancer Institute (NCI) Result Received: No Study Results Posted Website Link: https://ClinicalTrials.gov/show/NCT00541073...

Continue reading

Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery

Condition Malignant Mesothelioma Estimated Enrollment: null Age Group: 18 Years and older   (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Allocation: Randomized|Primary Purpose: Treatment Study ID Numbers: 99-085|CDR0000067791|CWRU-LILY-1599|LILLY-H3E-MC-JMCH(a)|NCI-G00-1767 Study First Received: May 2, 2000 Last Updated: June 17, 2013 Estimated Primary Completion Date: November 2000 Primary Outcome Measures: Sponsors and Collaborators: Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Result Received: No Study Results Posted Website Link: https://ClinicalTrials.gov/show/NCT00005636...

Continue reading

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

Condition Pleural Malignant Mesothelioma Estimated Enrollment: 14 Age Group: 18 Years and older   (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Primary Purpose: Treatment Study ID Numbers: UPCC 03510 Study First Received: April 27, 2010 Last Updated: December 14, 2015 Estimated Primary Completion Date: October 2012 Primary Outcome Measures: 3-month PFS rate|Estimate the distribution of progression-free and over survival Sponsors and Collaborators: Abramson Cancer Center of the University of Pennsylvania Result Received: No Study Results Posted Website Link: https://ClinicalTrials.gov/show/NCT01112293...

Continue reading

Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment

Condition Malignant Pleural Mesothelioma Estimated Enrollment: 78 Age Group: 18 Years to 85 Years   (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment Study ID Numbers: 86/12/02 Study First Received: November 10, 2010 Last Updated: November 17, 2010 Estimated Primary Completion Date: June 2010 Primary Outcome Measures: Response rate|Safety and tolerability Sponsors and Collaborators: Institute of Oncology Ljubljana|Ministry of Higher Education, Science and Technology, Solvenia Result Received: No Study Results Posted Website Link: https://ClinicalTrials.gov/show/NCT01243632...

Continue reading

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

Condition Malignant Pleural Mesothelioma Estimated Enrollment: 40 Age Group: 18 Years to 85 Years   (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment Study ID Numbers: MPM phase II Carbo/VNB Study First Received: January 3, 2006 Last Updated: September 17, 2009 Estimated Primary Completion Date: September 2009 Primary Outcome Measures: Response|Survival|Feasibility Sponsors and Collaborators: Rigshospitalet, Denmark Result Received: No Study Results Posted Website Link: https://ClinicalTrials.gov/show/NCT00272558...

Continue reading

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma

Condition Malignant (Pleural) Mesothelioma Estimated Enrollment: 10 Age Group: Child, Adult, Senior Gender: All Study Type: Interventional Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment Study ID Numbers: NL24050.000.08 Study First Received: June 1, 2010 Last Updated: February 26, 2014 Estimated Primary Completion Date: October 2011 Primary Outcome Measures: number of cytotoxic T cells and regulatory T cells in the blood of patients|safety and toxicity Sponsors and Collaborators: Erasmus Medical Center Result Received: No Study Results Posted Website Link: https://ClinicalTrials.gov/show/NCT01241682...

Continue reading

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

Condition Malignant Mesothelioma Estimated Enrollment: 25 Age Group: 18 Years and older   (Adult, Senior) Gender: All Study Type: Interventional Study Design Allocation: Primary Purpose: Treatment Study ID Numbers: EORTC-08992 Study First Received: January 28, 2000 Last Updated: July 17, 2012 Estimated Primary Completion Date: June 2001 Primary Outcome Measures: Sponsors and Collaborators: European Organisation for Research and Treatment of Cancer - EORTC Result Received: No Study Results Posted Website Link: https://ClinicalTrials.gov/show/NCT00004254...

Continue reading